Locations:

Tag: left atrial appendage (laa)

Boston Scientific Corporation WATCHMAN FLX Device

March 15, 2023/Heart, Vascular and Thoracic/Electrophysiology

Watchman FLX at 1 Year: Real-World Performance Consistent With Trial Results

Large SURPASS registry study confirms high seal rates, acceptable safety

March 16, 2022/Heart, Vascular and Thoracic/Electrophysiology

SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days

Interim report from large registry analysis compares favorably with pivotal trial

November 9, 2021/Heart, Vascular and Thoracic/Electrophysiology

Insights From 1,000+ Left Atrial Appendage Closure Procedures With Watchman

Even very high-risk patients benefit, and implantation can safely be combined with ablation or TAVR

October 15, 2021/Heart, Vascular and Thoracic/Electrophysiology

‘Convergent Plus’ Optimizes Hybrid Strategy for Persistent Atrial Fibrillation

Taking a combined surgical/electrophysiology strategy to the next level

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

April 16, 2018/Basic & Translational Science

Genetic Control of Left Atrial Gene Expression: A New Window into AFib Risk

Study’s genome-wide catalog should fuel investigations

BackPage 1 of 1Next